In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

While both Wegovy and Ozempic list “headache” as a common side effect that was found during the drugs’ clinical trials, many ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

Amanda Bynes has given fans a glimpse into her latest jewelry addition. Posting via her Instagram Stories on Thursday, July ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

Semaglutide is marketed under the brand names, such as Ozempic, which is primarily prescribed for those with Type 2 diabetes, and Wegovy, which is commonly prescribed for weight loss. The drug mimics ...

Whether identifying as Republicans or Democrats, about 70% of adults surveyed say health insurers exert too much influence ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Half of folks who say they always feel lonely (50%) have clinical depression, compared with just 10% of those who report ...

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are reporting. In very rare cases they can be deadly. Here’s what to know.